rs587777252
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_033419.5(PGAP3):c.914A>G(p.Asp305Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000651 in 1,613,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_033419.5 missense
Scores
Clinical Significance
Conservation
Publications
- hyperphosphatasia with intellectual disability syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- hyperphosphatasia-intellectual disability syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152184Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000200 AC: 5AN: 250438 AF XY: 0.0000369 show subpopulations
GnomAD4 exome AF: 0.0000670 AC: 98AN: 1461814Hom.: 0 Cov.: 30 AF XY: 0.0000660 AC XY: 48AN XY: 727214 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152184Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74346 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Published functional studies demonstrate mislocalization to the endoplasmic reticulum and significantly reduced GPI-anchored protein levels suggesting low residual enzyme activity (PMID: 24439110); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 24439110, 28327575, 30345601, 27535533, 37010288, 27120253) -
This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 305 of the PGAP3 protein (p.Asp305Gly). This variant is present in population databases (rs587777252, gnomAD 0.005%). This missense change has been observed in individual(s) with PGAP3-congenital disorder of glycosylation (PMID: 24439110, 28327575). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 125439). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PGAP3 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects PGAP3 function (PMID: 24439110). For these reasons, this variant has been classified as Pathogenic. -
Hyperphosphatasia with intellectual disability syndrome 4 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at